Jan Pontén
Impact in
Papers in
-
- Cancer Genomics and Diagnostics 11
- Oncology 41
- Cancer-related Molecular Pathways 11
- Global Cancer Incidence and Screening 10
- Co-authors
- Bengt WestermarkE. H. MacintyreKenneth NilssonHans‐Olov AdamiE SakselaFredrik PonténA. Macieira‐CoelhoLennart Philipson
- Journals
- International Journal of Cancer (21 papers)Experimental Cell Research (10 papers)JNCI Journal of the National Cancer Institute (7 papers)Journal of Cellular Physiology (7 papers)Acta Oncologica (4 papers)
- Partner nations
- SwedenUnited StatesFinland
In The Last Decade
Jan Pontén
162 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Oncology 2.3k
- Aging 135
- Cancer Research 986
- Immunology and Allergy 344
- Genetics 581
Countries citing papers authored by Jan Pontén
This map shows the geographic impact of Jan Pontén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Pontén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Pontén more than expected).
Fields of papers citing papers by Jan Pontén
This network shows the impact of papers produced by Jan Pontén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Pontén. The network helps show where Jan Pontén may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Pontén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 3 | |
| 2 | 2009 | 3 | |
| 3 | 2002 | 14 | |
| 4 | 2001 | 24 | |
| 5 | 1999 | 1 | |
| 6 | Precancer biology: importance and possible prevention. Introduction. | 1998 | 1 |
| 7 | Precancer: biology, importance and possible prevention | 1998 | 5 |
| 8 | 1994 | 47 | |
| 9 | 1994 | 75 | |
| 10 | 1994 | 64 | |
| 11 | 1993 | 11 | |
| 12 | 1992 | 23 | |
| 13 | 1990 | 61 | |
| 14 | 1990 | 22 | |
| 15 | 1989 | 28 | |
| 16 | 1988 | 5 | |
| 17 | Life span and 'immortalization' of mammalian cells. | 1985 | 1 |
| 18 | Residual bodies and "aging" in cultured human glia cells. Effect of entrance into phase 3 and prolonged periods of confluence. | 1973 | 82 |
| 19 | 1971 | 46 | |
| 20 | 1971 | 11 |
About Jan Pontén
Jan Pontén is a scholar working on Cancer Research, Oncology, Genetics, Epidemiology and Genetics, having authored 164 papers that have together received 8.2k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (22 papers), Virus-based gene therapy research (21 papers), Telomeres, Telomerase, and Senescence (17 papers), Molecular Biology Techniques and Applications (12 papers), RNA Interference and Gene Delivery (11 papers), Cancer-related Molecular Pathways (11 papers), Cancer Genomics and Diagnostics (11 papers) and Global Cancer Incidence and Screening (10 papers). The work is most often cited by research in Oncology (2.3k citations), Aging (135 citations), Cancer Research (986 citations), Immunology and Allergy (344 citations) and Genetics (581 citations). Jan Pontén has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Bengt Westermark, E. H. Macintyre, Kenneth Nilsson, Hans‐Olov Adami, E Saksela, Fredrik Pontén, A. Macieira‐Coelho, Lennart Philipson, Joakim Lundeberg and Monica Nistér. Their work appears in journals such as International Journal of Cancer, Experimental Cell Research, JNCI Journal of the National Cancer Institute, Journal of Cellular Physiology and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.